ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization

Most patients with neovascular age-related macular degeneration (nvAMD), the leading cause of severe vision loss in elderly US citizens, respond inadequately to current therapies targeting a single angiogenic mediator, vascular endothelial growth factor (VEGF). Here, we report that aqueous fluid lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yu, Dinabandhu, Aumreetam, Cao, Xuan, Sanchez, Jaron Castillo, Jee, Kathleen, Rodrigues, Murilo, Guo, Chuanyu, Zhang, Jing, Vancel, Jordan, Menon, Deepak, Khan, Noore-Sabah, Ma, Tao, Tzeng, Stephany Y., Daoud, Yassine, Green, Jordan J., Semenza, Gregg L., Montaner, Silvia, Sodhi, Akrit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310537/
https://www.ncbi.nlm.nih.gov/pubmed/35653189
http://dx.doi.org/10.1172/jci.insight.157896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310537/
https://www.ncbi.nlm.nih.gov/pubmed/35653189
http://dx.doi.org/10.1172/jci.insight.157896

Ejemplares similares